Interleukin-6 Receptor-Mediated Activation of Signal Transducer and Activator of Transcription-3 (STAT3) Promotes Choroidal Neovascularization
- 1 June 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (6) , 2149-2158
- https://doi.org/10.2353/ajpath.2007.061018
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (18790280)
This publication has 48 references indexed in Scilit:
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Angiotensin II Type 1 Receptor–Mediated Inflammation Is Required for Choroidal NeovascularizationArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic InterventionsPublished by Elsevier ,2005
- Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman diseaseBlood, 2005
- Inhibitors of Ocular NeovascularizationJAMA, 2005
- ICAM-1 induction by TNFα and IL-6 is mediated by distinct pathways via Rac in endothelial cellsJournal of Biomedical Science, 2005
- Hypertension-Induced End-Organ DamageHypertension, 1999
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- Isolation of Two Interleukin‐6 Response Element Binding Proteins from Acute Phase Rat LiversaAnnals of the New York Academy of Sciences, 1995
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990